Celularity (CELU) EBT (QoQ) (2019 - 2025)
Powered by 
Analysis
Celularity (CELU) EBT (QoQ) (2019 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.20 Bn | 9.35 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Celularity | 36.65 Mn | 30.48 Mn | -3.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -5.56% |
| Sep 30, 2025 | 5.90% |
| Jun 30, 2025 | -24.15% |
| Mar 31, 2025 | -48.60% |
| Dec 31, 2024 | 17.42% |
| Sep 30, 2024 | -148.12% |
| Jun 30, 2024 | 70.53% |
| Mar 31, 2024 | -330.33% |
| Dec 31, 2023 | 110.18% |
| Sep 30, 2023 | -95.78% |
| Jun 30, 2023 | 25.10% |
| Mar 31, 2023 | -361.86% |
| Dec 31, 2022 | 411.23% |
| Sep 30, 2022 | -90.00% |
| Jun 30, 2022 | 176.10% |
| Mar 31, 2022 | -1,463.86% |
| Dec 31, 2021 | -108.05% |
| Sep 30, 2021 | 177.45% |
| Jun 30, 2021 | 20.92% |
| Mar 31, 2021 | -2,222.86% |